Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Compounding Theme Archive
MARKETING, LEGAL, AND BUSINESS ISSUES

MARKETING, LEGAL, AND BUSINESS ISSUES

Permanent storage and easy retrieval of Journal articles and formulations.
  - Includes the full-color, searchable, PDF files of articles and formulations from the Journal.
  - Print Journal articles in color for your research and marketing needs.
  - Eliminate long searches through past issues for articles and formulations.



Only $95.00


(Select Format)
Mailed CD
Instant PDF Download

This archive contains the following articles listed by volume, issue and page number:

MARKETING RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy Vol. 22 No. 6 471
Compounding from a Pharmacy Student's Perspective Vol. 22 No. 4 281
Pharmacogenomics: Precision Pharmacy in 503A Compounding Vol. 22 No. 2 95
Why Become Pharmacy Compounding Accreditation Board Accredited? Vol. 20 No. 6 469
Bedside Manner: Not Just for Doctors Anymore Vol. 19 No. 2 115
Giving Back: A Win-Win Plan of Action for Compounding Pharmacists Vol. 19 No. 1 14
Marketing: Using Facebook to Market Your Compounding Pharmacy Vol. 18 No. 6 490
Marketing: Tips on Dealing With a Healthcare Practititioner's No-Rep Policy Vol. 18 No. 5 406
Marketing: Effective Use of Advertisements on Your Website Vol. 18 No. 3 210
Effective Advertisements Vol. 18 No. 2 120
Marketing Vol. 18 No. 1 38
Marketing During the Holidays Vol. 17 No. 6 482
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial Vol. 17 No. 3 262
Marketing: Overcoming Objections to Prescribing Compounded Medications Vol. 16 No. 6 484
Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients Vol. 16 No. 5 394
Okay, I've Got It: Now What Do I Do With It? Vol. 16 No. 4 310
Marketing: 16 Ways to Incorporate Facebook into Your Compounding Pharmacy Vol. 16 No. 3 224
Trade Shows: Planning Your Strategy Vol. 16 No. 2 134
7 Marketing Tactics That Don't Work Vol. 15 No. 5 388
7 Marketing Tactics That Don't Work, Part 3 Vol. 15 No. 4 320
7 Marketing Tactics That Don't Work, Part 2 Vol. 15 No. 3 222
Seven Marketing Tactics That Don't Work Vol. 15 No. 2 130
Marketing Vitamins, Minerals, and Other Nutrients Vol. 15 No. 1 44
Home Infusion Accreditation: Another Quality Recognition Branding Tool Vol. 14 No. 5 360
Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response Vol. 14 No. 5 366
Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging Vol. 14 No. 1 26
Compounding Pharmacy: A Unique Service for a Unique Population Vol. 14 No. 1 19
Marketing the Geriatric Patient Vol. 13 No. 6 538
Marketing Veterinarians Vol. 13 No. 5 410
An Abridged History of Aspirin Vol. 13 No. 5 404
Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study Vol. 13 No. 5 440
Optimizing Your Website: Search Engine Optimization, Pay Per Click, Email Marketing Vol. 13 No. 4 311
PreScription: A Good Name: Pharmacy Vol. 13 No. 3 180
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education Vol. 13 No. 3 224
Blogging for Business Vol. 13 No. 2 141
Technology for the Patient-Centric Pharmacy Vol. 12 No. 5 434
Marketing: Taking Your Show on the Road Vol. 12 No. 5 438
Branding: Give Your Small Business a Big Image Vol. 12 No. 6 537
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization Vol. 12 No. 4 334
Marketing for Your Community Vol. 12 No. 4 338
Developing a Niche Marketing Strategy Vol. 12 No. 3 242
Web 2.0 and Health 2.0: Are You In? Vol. 12 No. 3 244
Newsletters: An Essential Marketing Tool Vol. 12 No. 2 128
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care Vol. 12 No. 2 174
Websites: Keeping Current in 2008 Vol. 12 No. 1 48
PostScription: Consumer Options for Disposal of Unused Medications Vol. 12 No. 1 87
Standard Operating Procedure: Complaint and Mishap Rectification Vol. 11 No. 5 414
Book Review: The Rexall Story: A History of Genius and Neglect Vol. 11 No. 4 300
PostScription: IJPC—More Than a Journal Vol. 11 No. 1 88
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Vol. 10 No. 6 462
PreScription: Certification and Accreditation Vol. 10 No. 5 322
What are You Willing to Do? Vol. 10 No. 4 287
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Vol. 10 No. 3 175
Quick Tips for Managing Market Directors Vol. 10 No. 3 201
PreScription: The Squeaky Wheel Gets the Grease! Vol. 10 No. 2 82
How'd They Do That? Vol. 10 No. 1 46
Marketing Your Business for Success Vol. 9 No. 6 445
What Customers Want Vol. 9 No. 3 213
Communication Makes It or Breaks It Vol. 9 No. 2 133
The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime Vol. 9 No. 1 37
PostScription Vol. 8 No. 6 496
A Foot in the Door: Marketing Tips - Dealing With Personalities Vol. 8 No. 5 373
Case Reports: Their Impact Vol. 8 No. 4 266
A Foot in the Door: Building Relationships Builds Your Business Vol. 8 No. 3 197
Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo. Vol. 8 No. 2 107
Detailing Your Compounding Specialty Practice - Part 2: The Presentation Vol. 8 No. 2 113
Financially Speaking: Business Continuation Planning Vol. 8 No. 2 120
Detailing Your Compounding Specialty Practice: Part 1 - Prospecting, Preapproach and Approach Vol. 8 No. 1 31
A Foot in the Door: Marketing Tips Vol. 7 No. 6 454
How To Perform a Study in Your Pharmacy with Little or No Effort Vol. 6 No. 3 186
Developing a Successful Compounding Business in a Small Town Vol. 6 No. 2 108
A Guide to Effective Media Relations Vol. 6 No. 2 111
High-tech Marketing Techniques Vol. 5 No. 6 420
Formulations for Success, Part 2 Vol. 5 No. 4 287
Motivation and Management: How to Build Your Business into the Job You Love Vol. 5 No. 3 166
Pricing Strategies Vol. 5 No. 3 180
Pediatric Compounding: Coloring Outside the Lines Vol. 5 No. 1 6
Marketing Your Prescription Compounding Practice: Part Three Vol. 4 No. 3 199
Marketing Your Prescription Compounding Practice: Part Two Vol. 4 No. 2 115
Marketing Your Prescription Compounding Practice: Part One Vol. 4 No. 1 36
Marketing Tip: Marketing Reps Can Help Vol. 4 No. 1 39
Marketing Tip: Flavors: Target Marketing to Doctors and Patients Vol. 3 No. 6 454
Independent Pharmacists Score High with Consumers Vol. 3 No. 6 457
Planning and Marketing a Natural HRT Patient Seminar Vol. 3 No. 5 360
Marketing Tip: Collaboration Can Result in More Cost-Effective Seminars Vol. 3 No. 5 362
Marketing Tip: PR Can Help with Image Change and Geographic Expansion Vol. 3 No. 4 277
Marketing Tip: Teachable Moments: A Simple Concept Vol. 3 No. 3 199
Marketing Tip: Locator Maps Vol. 3 No. 2 127
HRT Marketing Tip Vol. 3 No. 1 37
Essential Truths About HRT Vol. 2 No. 1 10
Interview on HRT: Christiane Northrup, MD, FACOG Vol. 2 No. 1 12
HRT and the Continuing Education of Health Care Professionals Vol. 2 No. 1 18
Marketing to Veterinarians - Field Notes Vol. 1 No. 4 236

LEGAL RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: The NASEM cBHT Report, Part 1 Vol. 24 No. 6 444
NASEM Report on Compounded Topical Pain Creams Vol. 24 No. 6 446
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Vol. 24 No. 6 451
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 Vol. 24 No. 6 466
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Vol. 24 No. 5 356
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Vol. 24 No. 5 371
An Unconscionable, Unnecessary Fight Vol. 24 No. 5 386
PreScription: COVID-19 and Compounding Pharmacists Vol. 24 No. 4 268
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Vol. 24 No. 4 270
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Vol. 24 No. 4 296
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula Vol. 24 No. 4 322
U.S. Food and Drug Administration Takes Aim (Again) at Animal Compounding: Draft Guidance for Industry #256 Lacks Authority, Will Increase Costs, and Put Pets at Risk Vol. 24 No. 3 198
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Vol. 24 No. 2 92
A "North Star" for Pharmacy Compounders Vol. 24 No. 2 110
PreScription: One Size Does Not Fit All! Vol. 24 No. 1 4
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Vol. 24 No. 1 14
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Vol. 24 No. 1 21
New and Improved! Vol. 24 No. 1 28
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Vol. 24 No. 1 30
PreScription: As Things Change…. Vol. 23 No. 6 444
How to Qualify Container Closure Systems for Intended Use, Part 1 Vol. 23 No. 6 454
Are You Part of the Solution or Part of the Problem? Vol. 23 No. 6 462
PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc Vol. 23 No. 5 356
Threading the Needle Vol. 23 No. 5 383
Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future Vol. 23 No. 4 294
How to Develop and Maintain a Hazardous Drug List Vol. 23 No. 3 182
Can We Fix It? Vol. 23 No. 3 208
PreScription: Compounding with Cannabidiol Vol. 23 No. 2 92
Nimodipine Compounded Oral Suspension: A True Documented Medical Need Vol. 23 No. 2 106
Patient Access Is a Patient Safety Issue Vol. 23 No. 2 120
Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations Vol. 23 No. 2 135
An Outlook on the European and Italian Rules to Guarantee Magistral Formulas Vol. 23 No. 1 6
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Vol. 23 No. 1 32
Basics of Compounding: Standardization of Compounded Medications Vol. 23 No. 1 35
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Vol. 23 No. 1 47
Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Vol. 22 No. 6 475
PreScription: Updating Formulations Vol. 22 No. 5 356
Current Trends and Emerging Priorities in Compounded Preparations for Children Vol. 22 No. 5 358
Certification of Powder-containment Hoods for Nonsterile Compounding Vol. 22 No. 5 369
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Vol. 22 No. 5 387
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Vol. 22 No. 5 401
Your Presence is Needed at Compounders on Capitol Hill! Vol. 22 No. 3 204
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Vol. 22 No. 2 92
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Vol. 22 No. 2 108
IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing Vol. 22 No. 2 125
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Vol. 22 No. 2 129
PreScription: 2017--Some Good Things Happened and Some Others Vol. 22 No. 1 4
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Vol. 22 No. 1 7
The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives Vol. 22 No. 1 26
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement Vol. 21 No. 6 444
Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort! Vol. 21 No. 6 468
Validation of the Technological Process of the Preparation "Milk by Vidal" Vol. 21 No. 6 513
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Vol. 21 No. 5 356
Child-safety Containers/Devices and Compounding Vol. 21 No. 5 364
Documentation: Records and Reports Vol. 21 No. 5 373
IACP Legislative/Regulatory Update Vol. 21 No. 5 382
The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871 Vol. 21 No. 4 290
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives Vol. 21 No. 3 180
International Academy of Compounding Pharmacists Legislative/Regulatory Update Vol. 21 No. 3 212
PreScription: Whatever Happened to Common Sense? Vol. 21 No. 2 92
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Vol. 21 No. 2 95
The International Academy of Compounding Pharmacists Introduces a New President Vol. 21 No. 2 116
Quality Control: (Material) Safety Data Sheets Vol. 21 No. 2 118
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Vol. 21 No. 2 127
PreScription: Compounding Pharmacy Issues for 2017 Vol. 21 No. 1 4
When to Compound Medications for Veterinary Patients Vol. 21 No. 1 19
Why You Should Become an International Academy of Compounding Pharmacists Member Vol. 21 No. 1 28
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Vol. 20 No. 6 457
The "Lists": What Do They Mean? Vol. 20 No. 6 477
Basics of Compounding: Clinical Pharmaceutics, Part 2 Vol. 20 No. 6 485
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Vol. 20 No. 5 356
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Vol. 20 No. 5 367
More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard! Vol. 20 No. 5 377
Compounding Transdermal Medication for Feline Patients Vol. 20 No. 4 271
IACP's 2016 Compounders on Capitol Hill Asks Vol. 20 No. 4 294
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Vol. 20 No. 4 307
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Vol. 20 No. 4 351
PreScription: Patient Access to Pharmaceuticals Vol. 20 No. 3 180
Compounding in Nigeria Vol. 20 No. 3 189
IACP Names Voliva Executive Vice President Vol. 20 No. 3 194
PreScription: Compounding: A Changing Paradigm Vol. 20 No. 2 92
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations Vol. 20 No. 2 95
Microbial Identification in Pharmaceutical Compounding Vol. 20 No. 1 13
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success Vol. 20 No. 1 29
PostScription: The Home Field Advantage Vol. 20 No. 1 86
PreScription: The Documented Past and the Exciting Future Vol. 19 No. 6 442
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Vol. 19 No. 6 449
Applying Quality of Design Concepts to Pharmacy Compounding Vol. 19 No. 6 453
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Vol. 19 No. 6 487
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Vol. 19 No. 5 375
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Vol. 19 No. 5 377
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Vol. 19 No. 5 389
PostScription: Progress Report: Provider Status Continues to Gain Strength! Vol. 19 No. 5 437
PreScription: Potpourri of Opinions…From Many Vol. 19 No. 4 266
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Vol. 19 No. 4 303
Basics of Compounding: The "Negative" List Vol. 19 No. 4 311
IACP Says: "Fix DQSA" Vol. 19 No. 3 212
Quality Assurance and Quality Control, Part 2 Vol. 19 No. 3 215
PostScription: Opportunities to Change the Pharmacy Landscape Vol. 19 No. 3 271
New England Compounding Center Indictment Vol. 19 No. 2 94
Standing Together Fixing the Drug Quality and Security Act Vol. 19 No. 2 104
Standarized Compounding: The Importance of Doing it the Same Way Every Time Vol. 19 No. 2 109
PreScription: 2014 in Review Vol. 19 No. 1 4
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance Vol. 19 No. 1 30
Basics of Sterile Compounding: Aseptic Processing Vol. 19 No. 1 49
Basics of Compounding: The Revised "Not to Compound List" Vol. 19 No. 1 57
PostScription: Pharmacists Advancing Toward Provider Status Vol. 19 No. 1 86
Compounding Legislation: Focus Shifts to States Vol. 18 No. 6 470
PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future Vol. 18 No. 6 526
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Vol. 18 No. 5 379
Compounding Practices in a Portuguese Community Pharmacy Vol. 18 No. 5 392
PostScription: The Future of Veterinary Compounding Vol. 18 No. 5 438
PreScription: Challenging Times Vol. 18 No. 4 268
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Vol. 18 No. 4 270
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Vol. 18 No. 4 293
400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill Vol. 18 No. 4 302
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Vol. 18 No. 4 305
PreScription: Déjà Vu All Over Again Vol. 18 No. 3 180
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Vol. 18 No. 3 208
PreScription: Standards vs Opinions Vol. 18 No. 2 92
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Vol. 18 No. 2 101
Compounding Practices in Iran Vol. 18 No. 2 112
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Vol. 18 No. 2 117
PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year Vol. 18 No. 1 4
Good Enough for America Vol. 18 No. 1 20
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Vol. 18 No. 1 35
Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding Vol. 17 No. 6 477
HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now? Vol. 17 No. 6 480
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety Vol. 17 No. 6 485
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Vol. 17 No. 5 356
Compounding Pharmacies: Before and After an Inspection Vol. 17 No. 5 358
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms Vol. 17 No. 5 364
2013 State Compounding Legislation Tracker Updated: August 12, 2013 Vol. 17 No. 5 375
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters Vol. 17 No. 5 439
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Vol. 17 No. 4 283
Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover Vol. 17 No. 4 290
International Academy of Compounding Pharmacists Legislative/Regulatory Update Vol. 17 No. 4 302
PostScription: Traditional vs Nontraditional Pharmacy Vol. 17 No. 4 351
PreScription: Compounding for Drug Shortages Vol. 17 No. 3 180
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Vol. 17 No. 3 182
Decontamination Technology: The Missing Element Vol. 17 No. 3 193
International Academy of Compounding Pharmacists' Legislative/Regulatory Update Vol. 17 No. 3 206
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Vol. 17 No. 3 210
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Vol. 17 No. 3 238
PreScription: Pharmacy Committees Vol. 17 No. 2 92
Compounding in Ukraine Vol. 17 No. 2 124
International Academy of Compounding Pharmacists Legislative/Regulatory Update Vol. 17 No. 2 128
PreScription: Looking for Solutions Vol. 17 No. 1 4
Pediatric Health Care: An Introduction Vol. 17 No. 1 6
International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives Vol. 17 No. 1 48
PostScription: GMPs and GCPs: A Topical Comparison Vol. 17 No. 1 87
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Vol. 16 No. 6 446
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Vol. 16 No. 6 456
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 6 476
Quality Control: Analytical Methods. Certificates of Analysis, Part 1 Vol. 16 No. 6 486
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel Vol. 16 No. 6 490
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 5 382
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Vol. 16 No. 4 294
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 4 300
Selection of Color Additives: A Regulatory View Vol. 16 No. 4 304
PreScription: You're On Your Own Vol. 16 No. 3 180
PreScription: Working in Handcuffs Vol. 16 No. 3 180
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 3 220
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification Vol. 16 No. 3 230
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Vol. 16 No. 2 94
Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes Vol. 16 No. 2 98
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone Vol. 16 No. 1 86
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 16 No. 1 50
PreScription: Compounding: Keeping Elephants Our of Our Mouseholes Vol. 15 No. 6 444
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 15 No. 6 471
The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire Vol. 15 No. 6 474
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Vol. 15 No. 6 526
PreScription: Third-party Inequities and Discrimination Vol. 15 No. 5 356
Natural Tragedies: Planning for Disasters and Emergencies Vol. 15 No. 5 368
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 15 No. 5 382
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2 Vol. 15 No. 5 408
Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy Vol. 15 No. 4 278
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 15 No. 4 286
PreScription: Greed Does Not Pay! Makena, Lucentis, and Others Vol. 15 No. 3 180
PreScription: Making Things Right--Or Not? Vol. 15 No. 3 180
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Vol. 15 No. 3 218
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions Vol. 15 No. 3 224
PreScription: Discontinued Drugs and Drug Shortages Vol. 15 No. 2 92
PreScription: Compounding with Manufactured Products Vol. 14 No. 6 448
Home Infusion: Overcoming the Barriers to Entry Vol. 14 No. 6 450
PreScription: Compounding Veterinary Products: Needed but Problematic Vol. 14 No. 5 358
Home Infusion Accreditation: Another Quality Recognition Branding Tool Vol. 14 No. 5 360
PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle Vol. 14 No. 4 268
PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals Vol. 14 No. 4 268
PreScription: Healthcare Reform Is Not All That Is Happening in Washington Vol. 14 No. 3 180
PostScription: Healthcare Reform and Compounding Issues Vol. 14 No. 3 262
Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs Vol. 14 No. 2 131
PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort? Vol. 14 No. 2 174
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust Vol. 13 No. 6 532
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding Vol. 13 No. 6 525
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Vol. 13 No. 5 400
PostScription: Setting up a National System of Compounding Pharmacies: An Introduction Vol. 13 No. 5 447
PostScription: Compounding Pharmacy in Puerto Rico Vol. 13 No. 4 350
PreScription: Electronic Prescribing Vol. 13 No. 2 92
PostScription: Compounding in Argentina Vol. 13 No. 2 175
PreScription: A New Start: What Will 2009 Bring? Vol. 13 No. 1 4
PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective Vol. 13 No. 1 87
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Vol. 13 No. 1 56
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials Vol. 13 No. 1 81
Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information Vol. 12 No. 5 405
Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship Vol. 12 No. 5 410
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers Vol. 12 No. 5 414
Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered? Vol. 12 No. 5 420
Prescription: Is "Globalization" a Good Idea? Vol. 12 No. 6 474
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Vol. 12 No. 6 508
Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where Vol. 12 No. 6 514
PostScription: Supporting Compounding Around the World Vol. 12 No. 6 565
PreScription: First Estriol, Then What? Vol. 12 No. 4 284
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Vol. 12 No. 4 365
PostScription: It Is Not Just What You Say…But How You Say It! Vol. 12 No. 4 375
Estriol: Women's Choice vs. A Manufacturer's Greed Vol. 12 No. 4 286
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature Vol. 12 No. 4 329
Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization Vol. 12 No. 4 334
PreScription: Pain! Vol. 12 No. 3 180
Litigating the Legality of Compounding: The Medical Center Pharmacy Case Vol. 12 No. 3 238
Current Compounding Practices in Europe Vol. 12 No. 2 94
Compounding Around the World Vol. 12 No. 2 102
Establishing a Quality-Assurance Program for Hospital Compounding Vol. 12 No. 2 116
Hormone Therapy: It's Time for a Second Opinion Vol. 12 No. 2 122
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care Vol. 12 No. 2 174
PreScription: Year Number 12…And Still Much Work to Do Vol. 12 No. 1 4
Disposing of Expired Drugs and Chemicals: New Options for Compounders Vol. 12 No. 1 38
Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 Vol. 12 No. 1 63
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Vol. 12 No. 1 54
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Vol. 12 No. 1 74
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study Vol. 11 No. 6 450
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds Vol. 11 No. 6 487
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Vol. 11 No. 5 438
PreScription: Bias, NAMS, and HRT Vol. 11 No. 4 266
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature Vol. 11 No. 4 269
Premarin: The Intriguing History of a Controversial Drug Vol. 11 No. 4 282
The Politics of Hormone Replacement Therapy Vol. 11 No. 4 278
Quality-control Analytical Methods: Logbooks and Documentation Forms Vol. 11 No. 4 306
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Vol. 11 No. 4 314
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Vol. 11 No. 4 326
Statistical Analysis of Barrier Isolator/Glovebox Glove Failure Vol. 11 No. 4 338
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Vol. 11 No. 4 350
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Vol. 11 No. 3 220
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 Vol. 11 No. 3 230
Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form Vol. 11 No. 3 240
PostScription: Lobbying: How It Affects Compounding Vol. 11 No. 3 262
PreScription: State or Federal Control of Pharmacy Practice Vol. 11 No. 3 178
PreScription: Putting the Science Back into Pharmacy Vol. 11 No. 2 92
Certified Diabetes Educator: A Credential for Compounding Pharmacists Vol. 11 No. 2 112
Records and Record-Keeping for the Hospital Compounding Pharmacist Vol. 11 No. 2 138
PreScription: IJPC: The Next 10 Years Vol. 11 No. 1 2
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Vol. 11 No. 1 5
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Vol. 11 No. 1 56
Pharmacogenomics: The End of Trial-and-Error Medicine? Vol. 11 No. 1 59
PostScription: Challenges Facing an Analytical Laboratory Vol. 10 No. 6 479
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Vol. 10 No. 6 462
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Vol. 10 No. 6 446
Topical Cidofovir for Treatment of Resistant Viral Infections Vol. 10 No. 5 324
Education, Training, and Evaluation of Hospital Compounding Personnel Vol. 10 No. 5 361
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction Vol. 10 No. 5 377
PreScription: Standards, Legal Standards, and Accreditation Vol. 10 No. 3 162
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Vol. 10 No. 3 165
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Vol. 10 No. 3 175
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Vol. 10 No. 3 202
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Vol. 10 No. 3 208
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! Vol. 10 No. 3 240
PreScription: The Squeaky Wheel Gets the Grease! Vol. 10 No. 2 82
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist Vol. 10 No. 2 113
Pharmaceutical Legislation: An Historical Perspective Vol. 10 No. 1 20
Pharmacy Compounding Urban Legends Vol. 10 No. 1 32
Prescription: Pediatric Formulation Initiatives Vol. 9 No. 6 410
Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America Vol. 9 No. 5 332
Compounding: A Well-established Practice in 1938 Vol. 9 No. 5 364
Local Ventilation for Safe Containment in the Pharmaceutical Industry Vol. 9 No. 4 293
Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Vol. 9 No. 4 284
Survey of State Veterinary Compounding Laws and Regulations Vol. 9 No. 3 209
PostScription: AVMA's Position on Compounding for Animals Vol. 9 No. 3 247
Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer Vol. 9 No. 2 93
Standard Operating Procedure: SOP Master Book--Maintenance Vol. 9 No. 2 145
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Vol. 9 No. 2 127
Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations Vol. 9 No. 2 136
PostScription: Experts Everywhere Vol. 9 No. 2 167
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Vol. 9 No. 1 44
Is Veterinary Compounding Illegal Under Federal Law? Vol. 8 No. 6 449
PostScription: Your voice is important to the future of pharmacy Vol. 8 No. 5 407
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Vol. 8 No. 4 251
PostScription: Cleanroom Standards Vol. 8 No. 2 160
PostScription: The Wedgewood Case: What It Means for Pharmacies Vol. 8 No. 1 79
PreScription: Take Care with Terminology for Altered- and Slow-release Formulations Vol. 7 No. 6 418
PostScription: Changing Pharmacy Regulations Could Affect US Compounders Vol. 7 No. 6 495
Application of USP-NF Standards to Pharmacy Compounding Vol. 7 No. 5 361
HIPAA Privacy and Security for Providers: The Basics Vol. 7 No. 4 277
Containment of Hazardous Particulates in the Compounding Pharmacy Vol. 7 No. 4 281
Postcription: Does Your Pharmacy Practice Follow the Pharmacist Code of Ethics? Vol. 7 No. 4 320
Legal & Ethical Issues for Pharmacy Websites Vol. 7 No. 2 88
Regulatory and Operational Issues of Founding a Compounding Pharmacy Vol. 6 No. 6 434
Medications Discontinued in the United States Vol. 6 No. 6 441
Compounding and the Courts Vol. 6 No. 4 263
Facilities and Procedures for Compounding Hazardous Drugs Vol. 6 No. 4 267
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Vol. 6 No. 4 271
Legal Issues: Technicians in the Compounding Pharmacy Practice Vol. 6 No. 4 274
Medications Discontinued in the United States Vol. 6 No. 4 286
Medications Discontinued in the United States Vol. 6 No. 3 193
Medications Discontinued in the United States Vol. 6 No. 2 123
Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory Vol. 6 No. 2 149
Compounding with Controlled Substances Vol. 6 No. 1 8
The Problem of Drug Diversion Vol. 6 No. 1 11
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective Vol. 6 No. 1 13
PostScription: Regulatory Uncertainty Requires Professional Responsibility Vol. 6 No. 1 80
Compounding Issues and Accreditation Agencies Vol. 5 No. 4 273
The American Veterinary Medical Association Compounding Position Statement Vol. 5 No. 3 216
Establishing and Maintaining a Compounding Pharmacy Reference Library Vol. 5 No. 3 226
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Vol. 5 No. 2 97
Drugs Banned for Use in Food Animals: An Explanation Vol. 5 No. 2 101
From Wagon-Era Paregoric to Computer-Era Herbals Vol. 5 No. 2 112
Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing Vol. 5 No. 2 140
Assignment of a Beyond-Use Date for Compounded Preparations Vol. 4 No .6 474
Compounding Using Hazardous Drugs Vol. 4 No. 4 261
Compounding OTC Drugs: A Legal Perspective Vol. 4 No. 3 180
Pharmacy Licensure Requirements Vol. 4 No. 3 184
The Future of Compounding: An Industry Perspective Vol. 4 No. 3 204
Assignment of Beyond-Use Dates Vol. 4 No. 3 222
Analytical Testing of Extemporaneously Compounded Preparations Vol. 4 No. 2 105
When Problem Audits Strike Vol. 3 No. 6 458
When is Compounding for Animals Legal? Vol. 3 No. 3 188
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices Vol. 3 No. 2 126
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Vol. 3 No. 1 25
Opioids for Noncancer Pain: From Controversy to Consensus Vol. 2 No. 2 106
Firing an Employee - Without Getting Burned Vol. 2 No. 2 130
FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Vol. 1 No. 6 399
Aspirin in Chloroform (Chloroform Banned in US) Vol. 1 No. 6 407
The Decision to Compound Vol. 1 No. 2 71
The Compounding Pharmacist Vol. 1 No. 2 73
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies Vol. 1 No. 2 75

BUSINESS RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: The NASEM cBHT Report, Part 1 Vol. 24 No. 6 444
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Vol. 24 No. 1 21
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Vol. 23 No. 6 478
PreScription: Honesty/Ethics in Professions: The Gallup Polls Vol. 23 No. 3 180
Can We Fix It? Vol. 23 No. 3 208
Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy Vol. 22 No. 6 471
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Vol. 22 No. 5 401
Compounding from a Pharmacy Student's Perspective Vol. 22 No. 4 281
Your Presence is Needed at Compounders on Capitol Hill! Vol. 22 No. 3 204
Pharmacogenomics: Precision Pharmacy in 503A Compounding Vol. 22 No. 2 95
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Vol. 22 No. 1 7
Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting Vol. 21 No. 5 384
PreScription: Just Think About It! Vol. 21 No. 4 268
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives Vol. 21 No. 3 180
International Academy of Compounding Pharmacists Legislative/Regulatory Update Vol. 21 No. 3 212
PreScription: Compounding Pharmacy Issues for 2017 Vol. 21 No. 1 4
Why Become Pharmacy Compounding Accreditation Board Accredited? Vol. 20 No. 6 469
Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Vol. 20 No. 4 283
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Vol. 20 No. 4 307
Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives Vol. 20 No. 2 114
PostScription: The Home Field Advantage Vol. 20 No. 1 86
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Vol. 19 No. 6 514
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Vol. 19 No. 5 375
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Vol. 19 No. 5 377
Giving Back: A Win-Win Plan of Action for Compounding Pharmacists Vol. 19 No. 1 14
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous Vol. 18 No. 6 486
PreScription: Challenging Times Vol. 18 No. 4 268
Effective Advertisements Vol. 18 No. 2 120
Marketing Vol. 18 No. 1 38
PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services Vol. 18 No. 1 87
Compounding Pharmacies: Before and After an Inspection Vol. 17 No. 5 358
Quality Control Analytic Methods: Quality Planning, Part 1: A Holistic and Practical Approach Vol. 17 No. 5 393
Patient-centered Care as Value-added Service by Compounding Pharmacists Vol. 17 No. 4 339
PreScription: Compounding for Drug Shortages Vol. 17 No. 3 180
Optimizing Third-party Reimbursement for Compounded Medications Vol. 17 No. 3 201
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial Vol. 17 No. 3 262
PreScription: Pharmacy Committees Vol. 17 No. 2 92
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel Vol. 16 No. 6 490
Okay, I've Got It: Now What Do I Do With It? Vol. 16 No. 4 310
Marketing: 16 Ways to Incorporate Facebook into Your Compounding Pharmacy Vol. 16 No. 3 224
Trade Shows: Planning Your Strategy Vol. 16 No. 2 134
Quality Control: Undecided About Buying an In-House Water Purification System? Pros, Cons, and Caveats That May Provide the Answers You Need Vol. 15 No. 6 480
PreScription: Third-party Inequities and Discrimination Vol. 15 No. 5 356
7 Marketing Tactics That Don't Work Vol. 15 No. 5 388
PreScription: Greed Does Not Pay! Makena, Lucentis, and Others Vol. 15 No. 3 180
PreScription: Making Things Right--Or Not? Vol. 15 No. 3 180
Seven Marketing Tactics That Don't Work Vol. 15 No. 2 130
Home Infusion 101 Vol. 15 No. 1 6
A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management Vol. 15 No. 1 20
PostScription: Profile of a Pharmacy Compounding Accreditation Board–Accredited Pharmacy: Vital Care of Meridian Vol. 15 No. 1 86
Home Infusion: Overcoming the Barriers to Entry Vol. 14 No. 6 450
PostScription: Profile of a Pharmacy Compounding Accreditation Board Accredited Pharmacy: Avera Doctors Plaza 2 Pharmacy Vol. 14 No. 6 531
Quality Control Analytical Methods: Continuous Quality Improvement Vol. 14 No. 3 218
Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding: Suggestions on How to Avoid Being Terminated from the Pharmacy Benefits Manager Network Vol. 14 No. 2 134
Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes Vol. 14 No. 2 124
Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study Vol. 13 No. 5 440
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Vol. 13 No. 4 290
Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care? Vol. 13 No. 4 318
PostScription: Compounding in Israel Vol. 13 No. 3 262
PreScription: A Good Name: Pharmacy Vol. 13 No. 3 180
Tips for Cleanroom Construction and Renovation Vol. 13 No. 2 100
Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations Vol. 13 No. 2 106
Blogging for Business Vol. 13 No. 2 141
Incorporating Web Communication to Maximize Staff Productivity in a Compounding Pharmacy Vol. 13 No. 2 138
Technology for the Compounding Pharmacy: Digital Pens--Tools or Toys? Vol. 13 No. 1 50
PreScription: Compounding Around the World Vol. 12 No. 5 382
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers Vol. 12 No. 5 414
Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered? Vol. 12 No. 5 420
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations Vol. 12 No. 5 432
Technology for the Patient-Centric Pharmacy Vol. 12 No. 5 434
Prescription: Is "Globalization" a Good Idea? Vol. 12 No. 6 474
Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where Vol. 12 No. 6 514
Branding: Give Your Small Business a Big Image Vol. 12 No. 6 537
Web 2.0 and Health 2.0: Are You In? Vol. 12 No. 3 244
Newsletters: An Essential Marketing Tool Vol. 12 No. 2 128
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care Vol. 12 No. 2 174
Websites: Keeping Current in 2008 Vol. 12 No. 1 48
Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 Vol. 12 No. 1 63
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Vol. 12 No. 1 74
The Internet and Its Websites: Your New Business Partner Vol. 11 No. 6 472
The Whales: A Pharmacist's Story Vol. 11 No. 5 376
Standard Operating Procedure: Complaint and Mishap Rectification Vol. 11 No. 5 414
Premarin: The Intriguing History of a Controversial Drug Vol. 11 No. 4 282
Book Review: The Rexall Story: A History of Genius and Neglect Vol. 11 No. 4 300
The Politics of Hormone Replacement Therapy Vol. 11 No. 4 278
Records and Record-Keeping for the Hospital Compounding Pharmacist Vol. 11 No. 2 138
Information Resources and Software for the Hospital Compounding Pharmacist Vol. 11 No. 1 36
Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection Vol. 11 No. 1 50
Compounding In Crisis:The Aftermath of Hurricane Katrina Vol. 11 No. 1 28
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Vol. 11 No. 1 56
Calculations Vol. 11 No. 1 68
PostScription: IJPC—More Than a Journal Vol. 11 No. 1 88
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Vol. 10 No. 6 462
Education, Training, and Evaluation of Hospital Compounding Personnel Vol. 10 No. 5 361
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction Vol. 10 No. 5 377
What are You Willing to Do? Vol. 10 No. 4 287
Quick Tips for Managing Market Directors Vol. 10 No. 3 201
PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! Vol. 10 No. 3 240
PreScription: The Squeaky Wheel Gets the Grease! Vol. 10 No. 2 82
How'd They Do That? Vol. 10 No. 1 46
Profile: The McGuff Companies, Part 2: Corporate Cooperation Supports Growth and Ensures Financial Success Vol. 10 No. 1 50
Marketing Your Business for Success Vol. 9 No. 6 445
Profile: The McGuff Companies. Part 1: Compounding and Manufacturing Share Facilities and Build Corporate Success Vol. 9 No. 6 452
Back to the Basics of Business Vol. 9 No. 5 380
Standard Operating Procedure: Employee Personnel Records Vol. 9 No. 4 309
Book Reviews: When Change Is Your Company's Middle Name: The Professional's Guide to Understanding the Human Side of Business Transformation Vol. 9 No. 3 173
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Vol. 9 No. 3 201
Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer Vol. 9 No. 2 93
Standard Operating Procedure: SOP Master Book--Maintenance Vol. 9 No. 2 145
Communication Makes It or Breaks It Vol. 9 No. 2 133
The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime Vol. 9 No. 1 37
Defining Success Vol. 9 No. 1 42
Book Review: Good to Great: Why Some Companies Make the Leap and Others Don't Vol. 8 No. 6 412
A Foot in the Door: Marketing Tips - Dealing With Personalities Vol. 8 No. 5 373
Standard Operating Procedure: Pharmacy Computer System Access to and Maintenance of the Master Formula Records Vol. 8 No. 5 381
PostScription: Your voice is important to the future of pharmacy Vol. 8 No. 5 407
PreScription - Categories of Pharmaceutial Compounding Vol. 8 No. 4 242
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Vol. 8 No. 4 251
Rationale for a Pharmacists' Pharmacopeia Vol. 8 No. 4 285
PostScription: What is Evidence-Based Medicine? Vol. 8 No. 4 320
Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor Vol. 8 No. 3 162
Book and Literature Reviews Vol. 8 No. 3 164
Compounding in the Pharmacy Curriculum: Beyond the Basics Vol. 8 No. 3 181
Precepting: A Win-Win Situation for All Vol. 8 No. 3 194
A Foot in the Door: Building Relationships Builds Your Business Vol. 8 No. 3 197
Standard Operating Procedure: Disposal of Chemicals Vol. 8 No. 3 210
Quality-Control Analytical Methods: High-Performance Liquid Chromatography Vol. 8 No. 3 223
PostScription: How should a pharmacist be trained? Vol. 8 No. 3 240
Prescription - USP <795>, NABP and the Physician/patient/pharmacist relationship - From the Editor Vol. 8 No. 2 82
Literature Reviews Vol. 8 No. 2 84
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Vol. 8 No. 2 89
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Vol. 8 No. 2 101
Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo. Vol. 8 No. 2 107
Detailing Your Compounding Specialty Practice - Part 2: The Presentation Vol. 8 No. 2 113
Financially Speaking: Business Continuation Planning Vol. 8 No. 2 120
Calibration/Validation of Incubator Temperature Vol. 8 No. 2 130
Quality-Control Analytical Methods: Osmolality and Osmometry Vol. 8 No. 2 143
PostScription: Cleanroom Standards Vol. 8 No. 2 160
Prescription-Who and/or What is IJPC and the subject of pharmacy practice and compounding pharmacy-From the Editor Vol. 8 No. 1 2
Book & Literature Reviews Vol. 8 No. 1 4
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP Vol. 8 No. 1 22
Detailing Your Compounding Specialty Practice: Part 1 - Prospecting, Preapproach and Approach Vol. 8 No. 1 31
Developing and Providing Compounding Services for Hospitals Involved in a Merger Vol. 8 No. 1 36
American Pharmaceutical Patents From a Historical Perspective Vol. 8 No. 1 40
Handling of Syringes and Needles Vol. 8 No. 1 49
Quality-Control Analytical Methods: Selecting an Analytical Method Vol. 8 No. 1 61
Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy Vol. 8 No. 1 65
Compounding for Investigational Studies: The Experience of Ken Hughes, RPh Vol. 7 No. 6 436
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care Vol. 7 No. 6 441
A Foot in the Door: Marketing Tips Vol. 7 No. 6 454
Technology Spotlight: Automated Prescription-Dispensing Systems Vol. 7 No. 6 458
PostScription: Changing Pharmacy Regulations Could Affect US Compounders Vol. 7 No. 6 495
Book and Literature Reviews Vol. 7 No. 5 324
Postcriptions: Compounding Paradox: Taught Less and Practiced More Vol. 7 No. 5 399
Calculations Vol. 7 No. 5 372
An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices Vol. 7 No. 5 401
Book Reviews Vol. 7 No. 4 244
Literature Review Vol. 7 No. 4 246
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT Vol. 7 No. 4 258
HIPAA Privacy and Security for Providers: The Basics Vol. 7 No. 4 277
Further Clarification of HIPAA Regulations Vol. 7 No. 3 195
Software for the Compounding Pharmacist: An Update Vol. 7 No. 3 197
Legal & Ethical Issues for Pharmacy Websites Vol. 7 No. 2 88
Profile of a Practice: Building a Compounding Pharmacy Practice from the Ground Up: Prescription Compounding Solutions, Medford, Oregon Vol. 7 No. 2 101
Barcode System and Computerized Balance Speed Compounding and Enhance Accuracy Vol. 7 No. 2 118
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Vol. 7 No. 1 21
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 2 Vol. 7 No. 1 32
Postcription: Future Trends in High Technology Pharmaceutical Compounding Vol. 7 No. 1 80
The Cost of Quality in Pharmacy Vol. 6 No. 6 404
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1 Vol. 6 No. 6 428
Regulatory and Operational Issues of Founding a Compounding Pharmacy Vol. 6 No. 6 434
Medications Discontinued in the United States Vol. 6 No. 6 441
Navigating New Territories in Compounding for Veterinary Medicine Vol. 6 No. 5 324
Rites of Passage Vol. 6 No. 5 337
Quality in Pharmacy: The New Zealand Experience Vol. 6 No. 5 354
Third-Party Contracting for Compounding Pharmacies Vol. 6 No. 5 359
Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy Vol. 6 No. 5 377
Establishing an Andropause Practice Vol. 6 No. 4 259
Compounding and the Courts Vol. 6 No. 4 263
Legal Issues: Technicians in the Compounding Pharmacy Practice Vol. 6 No. 4 274
Excerpts from and Reviews of Current Published Literature: Pharmacy Administration and Other Topics of Interest Vol. 6 No. 4 278
Magnetic Iron “Whiskers” in Cereals Vol. 6 No. 4 281
Medications Discontinued in the United States Vol. 6 No. 4 286
How To Perform a Study in Your Pharmacy with Little or No Effort Vol. 6 No. 3 186
Medications Discontinued in the United States Vol. 6 No. 3 193
pH and Osmolarity, A Review of Vol. 6 No. 3 216
Developing Standard Operating Procedures Vol. 6 No. 3 224
Developing a Successful Compounding Business in a Small Town Vol. 6 No. 2 108
A Guide to Effective Media Relations Vol. 6 No. 2 111
Medications Discontinued in the United States Vol. 6 No. 2 123
Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory Vol. 6 No. 2 149
Compounding with Controlled Substances Vol. 6 No. 1 8
The Problem of Drug Diversion Vol. 6 No. 1 11
Team Building For Success Vol. 6 No. 1 27
Safety for Employees in the Compounding Work Area Vol. 6 No. 1 60
High-tech Compounding: State-of-the-art Equipment Improves Products and Profit Vol. 5 No. 6 412
High-tech Rx Compliance Vol. 5 No. 6 419
High-tech Marketing Techniques Vol. 5 No. 6 420
Training Personnel Vol. 5 No. 6 474
Compounding Issues and Accreditation Agencies Vol. 5 No. 4 273
Analytical Testing Facilities and Products Vol. 5 No. 4 284
Formulations for Success, Part 2 Vol. 5 No. 4 287
Motivation and Management: How to Build Your Business into the Job You Love Vol. 5 No. 3 166
A New Trend in Pharmacy Practice: Private Consultations Vol. 5 No. 3 170
Formulations for Success in Compounding, Part 1 Vol. 5 No. 3 174
Developing a Business Plan for a Compounding Specialty Pharmacy Vol. 5 No. 3 176
Pricing Strategies Vol. 5 No. 3 180
The Pharmacist Manpower Shortage: How to Recruit and Retain Key Employees Vol. 5 No. 3 182
Book Reviews: Business Topics for Compounding Pharmacists Vol. 5 No. 3 185
Software for the Compounding Pharmacist: A Review Vol. 5 No. 3 187
Compounding in History: Compounding Economics Vol. 5 No. 3 196
Pharmacy Cleanroom Project Management Considerations: An Experience-Based Perspective Vol. 5 No. 3 221
Establishing and Maintaining a Compounding Pharmacy Reference Library Vol. 5 No. 3 226
Profile of a Practice: Custom Rx Compounding and Natural Pharmacy Vol. 5 No. 2 118
Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing Vol. 5 No. 2 140
Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding Vol. 5 No. 2 147
Profile of a Practice Vol. 5 No. 1 32
Sterile-Product Preparations: Mix or Buy? Vol. 5 No. 1 59
On-Line Billing for Custom Compounds: The Third-Party Payor Vol. 4 No .6 445
Profile of a Practice: Med Specialties Pharmacy Vol. 4 No .6 448
Profile of A Practice: Hormone Replacement Therapy in the Heartland Vol. 4 No. 5 362
Profile of a Practice Vol. 4 No. 4 287
Pharmacy Licensure Requirements Vol. 4 No. 3 184
Profile of a Practice: Surviving the Competition Vol. 4 No. 3 203
The Future of Compounding: An Industry Perspective Vol. 4 No. 3 204
Marketing Your Prescription Compounding Practice: Part Two Vol. 4 No. 2 115
Profile of a Practice Vol. 4 No. 2 120
Marketing Your Prescription Compounding Practice: Part One Vol. 4 No. 1 36
Marketing Tip: Marketing Reps Can Help Vol. 4 No. 1 39
Profile of a Practice Vol. 4 No. 1 40
Calibration of Hot Plates Vol. 4 No. 1 65
Profile of a Practice: Going the Extra Mile with Pharmaceutical Care Vol. 3 No. 6 455
Independent Pharmacists Score High with Consumers Vol. 3 No. 6 457
When Problem Audits Strike Vol. 3 No. 6 458
Finding the Balance Vol. 3 No. 5 340
Compounding Practice Structures Vol. 3 No. 5 368
Closing in on 2000: Your Y2K Report Vol. 3 No. 5 371
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding Vol. 3 No. 4 253
Profile of a Practice Vol. 3 No. 4 288
Improving Profitability with Veterinary Compounding Vol. 3 No. 3 180
Value and Pricing: Figuring Out What You're Worth Vol. 3 No. 3 197
The BPS Pharmacy Specialty Certification Program Vol. 3 No. 3 200
Profile of a Practice Vol. 3 No. 2 116
Personal Computing: Take Care When Choosing a Computer Consultant Vol. 3 No. 2 122
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices Vol. 3 No. 2 126
Issues and Opportunities: Compounding for Dentistry Vol. 3 No. 1 4
Audit Problems for Compounding Pharmacies Vol. 3 No. 1 36
HRT Marketing Tip Vol. 3 No. 1 37
Profile of a Practice Vol. 3 No. 1 39
Physical Requirements for a Nuclear Pharmacy Vol. 2 No. 6 426
Comparison of Job Satisfaction for Compounders and Noncompounders Vol. 2 No. 6 455
Required Documentation for Home Infusion Pharmacies - Compounding Records Vol. 2 No. 5 354
Third Party Contracts and the Compounding Pharmacy Vol. 2 No. 4 286
A Glimpse Into the Future Vol. 2 No. 3 203
An Eye to Success Vol. 2 No. 3 205
Profile of a Practice: Office Practice Facilitates Compounding and Patient Counseling Vol. 2 No. 3 219
Firing an Employee - Without Getting Burned Vol. 2 No. 2 130
Problems with Third-Party Payments for Compounded Prescriptions Vol. 2 No. 2 134
Hiring Good People Vol. 2 No. 1 38
PostScription: Independent Pharmacy: Alive and Well Vol. 2 No. 1 96
FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Vol. 1 No. 6 399
What Makes Pharmacists Different? Vol. 1 No. 4 214
Building a Compounding Lab: Remodeling an Existing Facility or Starting from Scratch? Vol. 1 No. 3 156
Patient Handouts Vol. 1 No. 3 160
The Decision to Compound Vol. 1 No. 2 71
The Compounding Pharmacist Vol. 1 No. 2 73
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies Vol. 1 No. 2 75
PostScription: Growing the Tree of Pharmacy Vol. 1 No. 2 136
Hospice Care and the Pharmacist Vol. 1 No. 1 11
The Ten Basic Steps in Filling a Prescription: Then and Now Vol. 1 No. 1 14
An Ancient Heritage Beckons Pharmacists Vol. 1 No. 1 22
Electronic Balance Maintenance/Calibration Vol. 1 No. 1 45
General Guidelines for Use of Chemicals for Prescription Compounding Vol. 1 No. 1 46
PostScription: The 90s Pharmacist Vol. 1 No. 1 64